-DOCSTART-	O

Action	O
of	O
fengsuidan	O
granules	O
on	O
experimental	O
anti-oral	B-NEG
ulcer	I-NEG
.	O

-DOCSTART-	O

Furthermore	O
,	O
the	O
effects	O
of	O
Juzentaihoto	O
were	O
clearly	O
revealed	O
on	O
the	O
histological	O
findings	O
of	O
testis	B-NEG
and	O
kidney	B-NEG
.	O

-DOCSTART-	O

OBJECTIVE	O
To	O
study	O
the	O
chemical	O
constituents	O
with	O
antiviral	O
action	O
from	O
Yinqiaosan	O
on	O
influenza	B-NEG
virus	I-NEG
.	O

-DOCSTART-	O

Tokishakuyakusan	O
(	O
TS	O
)	O
in	O
vivo	O
did	O
not	O
affect	O
the	O
changes	O
in	O
DNA	B-NEG
polymerase	I-NEG
alpha	I-NEG
and	I-NEG
beta	I-NEG
activities	I-NEG
during	O
the	O
estrous	O
cycle	O
.	O

-DOCSTART-	O

Debridement	O
,	O
injection	O
and	O
drug	O
covering	O
of	O
ulcer	B-NEG
surfaces	O
were	O
followed	O
by	O
oral	O
Chinese	O
medicine	O
Chuanjia	O
Weidan	O
(	O
50	O
g	O
daily	O
)	O
or	O
cimetidine	O
(	O
800	O
mg	O
every	O
night	O
)	O
for	O
4	O
weeks	O
.	O

-DOCSTART-	O

Saibokuto	O
suppressed	O
the	O
induction	O
of	O
IL2	B-NEG
responsiveness	I-NEG
induced	O
by	O
Dermatophagoides	O
farinae	O
(	O
Df	O
)	O
antigen	O
in	O
peripheral	O
blood	O
mononuclear	O
cells	O
from	O
patients	O
with	O
bronchial	B-NEG
asthma	I-NEG
.	O

-DOCSTART-	O

Effects	O
of	O
injectio	O
reduqing	O
on	O
plasma	B-NEG
IL-8	I-NEG
and	I-NEG
nitric	I-NEG
oxide	I-NEG
levels	I-NEG
in	O
rabbits	O
with	O
endotoxin	O
induced	O
disseminated	B-NEG
intravascular	I-NEG
coagulation	I-NEG
.	O

-DOCSTART-	O

The	O
recombinant	O
plasmid	O
pAGO	O
contains	O
the	O
Herpes	B-NEG
simplex	I-NEG
virus	I-NEG
type	I-NEG
1	I-NEG
(	I-NEG
HSV-1	I-NEG
)	I-NEG
thymidine	I-NEG
kinase	I-NEG
(	I-NEG
TK	I-NEG
)	I-NEG
gene	I-NEG
and	O
consists	O
of	O
a	O
2-kb	O
PvuII	O
fragment	O
of	O
HSV-1	O
DNA	O
inserted	O
into	O
the	O
PvuII	O
site	O
of	O
pBR322	O
.	O

-DOCSTART-	O

BACKGROUND	O
AND	O
PURPOSE	O
Chinese	O
herbal	O
medicine	O
,	O
Hochuekkito	O
is	O
widely	O
used	O
for	O
male	B-NEG
infertility	I-NEG
in	O
Japan	O
.	O

-DOCSTART-	O

To	O
examine	O
self-reported	O
quality	O
of	O
life	O
and	O
health	O
status	O
of	O
HIV	B-NEG
-infected	O
women	O
and	O
a	O
comparison	O
sample	O
of	O
HIV-uninfected	O
women	O
in	O
rural	O
Uganda	O
,	O
we	O
culturally	O
adapted	O
a	O
Lugandan	O
version	O
of	O
the	O
Medical	O
Outcomes	O
Survey-HIV	O
(	O
MOS-HIV	O
)	O
.	O

-DOCSTART-	O

METHODS	O
Eight	O
confirmed	O
HIV	B-NEG
AIDS	B-NEG
patients	O
(	O
AC1	O
,	O
ARC	O
6	O
,	O
AIDS	O
1	O
)	O
were	O
treated	O
with	O
TCM	O
recipes	O
(	O
802	O
,	O
806	O
,	O
809	O
,	O
810	O
,	O
Shengmaiyin	O
,	O
ZY-1	O
)	O
,	O
recheck	O
the	O
serum	O
antibody	O
and	O
immunological	O
function	O
and	O
intranuclear	O
HIV-DNA	O
was	O
investigated	O
with	O
PCR	O
amplifying	O
assay	O
and	O
were	O
long-term	O
followed-up	O
.	O

-DOCSTART-	O

The	O
results	O
suggest	O
Foshousan	O
plus	O
Danshen	O
can	O
protect	O
erythrocytes	O
against	O
lipid	B-NEG
peroxidation	I-NEG
damage	I-NEG
,	O
thus	O
conserving	O
the	O
normal	O
form	O
,	O
structure	O
and	O
function	O
of	O
erythrocytes	O
,	O
improving	O
the	O
uteroplacental	B-NEG
blood	I-NEG
flow	I-NEG
and	O
thereby	O
increasing	O
the	O
fetal	O
mean	O
birth	B-NEG
weight	I-NEG
.	O

-DOCSTART-	O

Saireito	O
(	O
a	O
Chinese	O
herbal	O
drug	O
)	O
decreases	O
inhibitory	O
effect	O
of	O
prednisolone	O
and	O
accelerates	O
the	O
recovery	O
of	O
rat	O
hypothalamic-pituitary-adrenal	B-NEG
axis	I-NEG
.	O

-DOCSTART-	O

When	O
the	O
liver	B-NEG
treated	O
with	O
Daisaikoto	O
was	O
perfused	O
,	O
the	O
effect	O
of	O
dietary	O
cholesterol	B-NEG
on	O
the	O
production	O
of	O
lipoprotein	O
and	O
apolipoprotein	O
was	O
markedly	O
diminished	O
.	O

-DOCSTART-	O

Effects	O
of	O
Yunqitang	O
on	O
both	O
esophageal	B-NEG
mucosal	I-NEG
morphology	I-NEG
and	O
esophageal	B-NEG
motility	I-NEG
in	O
reflux	B-NEG
esophagitis	I-NEG
patients	O
.	O

-DOCSTART-	O

The	O
history	O
of	O
the	O
present	O
illness	O
indicated	O
that	O
for	O
past	O
two	O
years	O
,	O
she	O
had	O
been	O
taking	O
a	O
Chinese	O
herbal	O
medicine	O
(	O
Shosaikoto	O
)	O
,	O
believed	O
to	O
be	O
used	O
for	O
the	O
treatment	O
of	O
liver	B-NEG
dysfunction	I-NEG
of	O
unknown	O
etiology	O
.	O

-DOCSTART-	O

Treatment	O
of	O
C6-glial	B-NEG
cells	I-NEG
with	O
LPS	B-NEG
PMA	B-NEG
induced	O
the	O
transcriptional	B-NEG
activation	I-NEG
of	I-NEG
NF-kappaB	I-NEG
,	O
which	O
was	O
markedly	O
inhibited	O
by	O
Samultang	O
.	O

-DOCSTART-	O

RESULTS	O
The	O
Reduqing	O
eye	O
drop	O
at	O
maximal	O
non-toxic	O
concentration	O
could	O
obviously	O
inhibit	O
the	O
cytopatic	B-NEG
effect	I-NEG
induced	O
by	O
100TCID50	O
and	O
10TCID50	O
HSV-I	O
.	O

-DOCSTART-	O

However	O
,	O
there	O
were	O
no	O
significant	O
changes	O
in	O
the	O
arteriolar	B-NEG
diameter	I-NEG
and	O
the	O
heart	B-NEG
rate	I-NEG
in	O
all	O
groups	O
treated	O
with	O
or	O
without	O
Sinitang	O
.	O

-DOCSTART-	O

Kampo	O
preparations	O
for	O
prostatic	B-NEG
hyperplasia	I-NEG
usefulness	O
of	O
Saireito	O
for	O
nocturia	B-NEG
.	O

-DOCSTART-	O

OBJECT	O
To	O
perform	O
experimental	O
pharmacodynamic	B-NEG
evaluation	O
of	O
a	O
new	O
TCM	O
antidiabetic	O
drug	O
Yitangyin	O
(	O
YTY	O
)	O
.	O

-DOCSTART-	O

The	O
mitogenic	O
activities	O
of	O
PMA	B-NEG
and	O
PHA	B-NEG
were	O
elevated	O
by	O
low	O
doses	O
of	O
Shosaikoto	O
and	O
Daisaikoto	O
and	O
suppressed	O
by	O
high	O
doses	O
.	O

-DOCSTART-	O

For	O
a	O
while	O
,	O
the	O
water	O
extract	O
of	O
Jagamchotang	O
stimulates	O
myocardial	B-NEG
cells	I-NEG
in	I-NEG
ischemic	I-NEG
condition	O
to	O
produce	O
nitric	B-NEG
oxide	I-NEG
(	O
NO	B-NEG
)	O
in	O
a	O
dose	O
dependent	O
manner	O
and	O
it	O
protects	O
the	O
damage	B-NEG
of	I-NEG
myocardial	I-NEG
cells	I-NEG
.	O

-DOCSTART-	O

From	O
the	O
above	O
findings	O
Seishinrenshiin	O
was	O
expected	O
to	O
be	O
both	O
effective	O
for	O
the	O
patients	O
who	O
have	O
constitutionally	O
infirm	O
stomach	B-NEG
and	O
intestines	B-NEG
and	O
can	O
be	O
used	O
safely	O
.	O

-DOCSTART-	O

As	O
a	O
result	O
,	O
in	O
the	O
case	O
of	O
rats	O
with	O
carrageenin	O
cotton	O
pellet-induced	O
granuloma	O
,	O
a	O
significant	O
inhibitory	O
effect	O
on	O
granuloma	B-NEG
formation	I-NEG
was	O
observed	O
in	O
the	O
Orengedokuto	O
treated	O
rats	O
(	O
150	O
mg	O
kg	O
day	O
)	O
which	O
showed	O
a	O
decrease	O
in	O
serum	O
lipid	O
peroxide	O
(	O
p	O
0	O
.	O
001	O
)	O
and	O
an	O
increase	O
in	O
acid	O
soluble	O
glycoprotein	O
(	O
p	O
0	O
.	O
001	O
)	O
.	O

-DOCSTART-	O

Goshajinkigan	O
(	O
niu-che-shen-qi-wan	O
in	O
Chinese	O
)	O
,	O
a	O
traditional	O
herbal	O
medicine	O
,	O
has	O
been	O
used	O
in	O
Japan	O
to	O
treat	O
clinical	O
symptoms	O
of	O
diabetic	B-NEG
neuropathy	I-NEG
.	O

-DOCSTART-	O

These	O
results	O
suggest	O
that	O
tokishakuyakusan	O
improves	O
luteal	B-NEG
insufficiency	I-NEG
in	O
women	O
but	O
does	O
not	O
affect	O
the	O
hormonal	O
levels	O
of	O
women	O
with	O
normal	O
menstrual	O
cycles	O
.	O

-DOCSTART-	O

Seven	O
days	O
after	O
hCG	B-NEG
treatment	O
,	O
the	O
resected	O
ovaries	O
were	O
incubated	O
in	O
vitro	O
with	O
herbal	O
components	O
of	O
Tokishakuyakusan	O
(	O
TS	O
)	O
.	O

-DOCSTART-	O

These	O
observations	O
confirm	O
that	O
Goshajinkigan	O
relieves	O
subjective	O
symptoms	O
and	O
demonstrate	O
that	O
it	O
improves	O
vibration	B-NEG
sensation	O
in	O
patients	O
with	O
diabetic	O
neuropathy	O
.	O

-DOCSTART-	O

The	O
older	O
ganglion	B-NEG
cells	O
also	O
express	O
a	O
slowly	O
activating	O
K	O
(	O
)	O
current	O
(	O
IKsa	O
)	O
.	O

-DOCSTART-	O

Since	O
this	O
theoryis	O
not	O
found	O
in	O
medical	O
books	O
before	O
the	O
Tang	O
era	O
,	O
and	O
since	O
many	O
examples	O
can	O
be	O
found	O
in	O
the	O
Heji	O
Jufang	O
and	O
other	O
medical	O
books	O
of	O
the	O
same	O
period	O
,	O
we	O
believe	O
this	O
is	O
a	O
view	O
of	O
pathology	O
peculiar	O
to	O
the	O
Northern	O
Sung	O
era	O
.	O
(	O
2	O
)	O
A	O
comparison	O
of	O
the	O
components	O
of	O
prescriptions	O
used	O
in	O
the	O
Waitai	O
Miyaofang	O
and	O
the	O
tanyin	O
chapter	O
of	O
the	O
Heji	O
Jufang	O
revealed	O
that	O
the	O
former	O
contains	O
many	O
strong	O
diuretics	O
,	O
purgatives	O
,	O
and	O
crude	O
drugs	O
of	O
a	O
hot	O
nature	O
,	O
while	O
the	O
later	O
contains	O
few	O
of	O
these	O
but	O
many	O
diuretics	O
that	O
have	O
a	O
mild	O
antitussive	B-NEG
effect	I-NEG
.	O

-DOCSTART-	O

The	O
effect	O
of	O
Tokishakuyakusan	O
(	O
TS	O
)	O
or	O
Keishibukuryogan	O
(	O
KB	O
)	O
on	O
endothelin-1	B-NEG
(	O
ET-1	O
)	O
,	O
a	O
newly	O
identified	O
peptide	O
,	O
in	O
plasma	O
and	O
amniotic	O
fluid	O
from	O
TS-	O
or	O
KB-treated	O
women	O
or	O
normal	O
pregnant	O
women	O
following	O
TS	O
or	O
KB	O
treatment	O
was	O
studied	O
during	O
the	O
menstrual	O
cycle	O
,	O
gestation	O
,	O
delivery	O
and	O
the	O
post-partum	O
period	O
.	O

-DOCSTART-	O

Hachimijiogan	O
(	O
H	O
)	O
,	O
its	O
components	O
and	O
Ninjin	O
(	O
N	O
)	O
were	O
administered	O
orally	O
to	O
the	O
animals	O
for	O
28	O
days	O
,	O
and	O
the	O
weight	B-NEG
of	O
the	O
various	O
organs	O
,	O
pituitary	O
content	O
of	O
FSH	O
,	O
LH	O
and	O
PRL	O
,	O
and	O
serum	O
concentration	O
of	O
FSH	B-NEG
,	O
LH	B-NEG
,	O
PRL	B-NEG
and	O
testosterone	B-NEG
were	O
measured	O
.	O

-DOCSTART-	O

The	O
above	O
anti-glucocorticoids	O
and	O
the	O
m-RNA	O
and	O
protein	O
synthesis	O
inhibitors	O
suppressed	O
the	O
anti-inflammatory	B-NEG
effects	I-NEG
of	O
Daisaikoto	O
and	O
Shosaikoto	O
dose-dependently	O
.	O

-DOCSTART-	O

Effects	O
of	O
kamikihito	O
,	O
a	O
traditional	O
Chinese	O
medicine	O
,	O
on	O
neurotransmitter	B-NEG
receptor	I-NEG
binding	I-NEG
in	O
the	O
aged	O
rat	O
brain	O
determined	O
by	O
in	O
vitro	O
autoradiography	O
(	O
1	O
)	O
Changes	O
in	O
the	O
3H	B-NEG
QNB	I-NEG
binding	I-NEG
.	O

-DOCSTART-	O

Subjects	O
were	O
208	O
persons	O
with	O
dental	B-NEG
fear	I-NEG
who	O
were	O
telephone	O
interviewed	O
,	O
of	O
whom	O
a	O
subsample	O
of	O
155	O
responded	O
to	O
a	O
mailed	O
Dental	O
Anxiety	O
Scale	O
(	O
DAS	O
)	O
,	O
State-Trait	O
Anxiety	O
Inventory	O
and	O
a	O
modified	O
FSS-II	O
Geer	O
Fear	O
Scale	O
(	O
GFS	O
)	O
.	O

-DOCSTART-	O

In	O
this	O
study	O
,	O
we	O
found	O
that	O
5-hydroxytryptophan	O
(	O
5-HTP	O
)	O
induced	O
decrease	O
in	O
locomotor	O
activity	O
was	O
significantly	O
antagonized	O
by	O
Suanzaorentang	O
,	O
p-chlorophenylalanine	B-NEG
(	O
p-CPA	O
)	O
induced	O
increase	O
in	O
locomotor	O
activity	O
was	O
significantly	O
inhibited	O
by	O
Suanzaorentang	O
,	O
Suanzaorentang	O
had	O
no	O
significant	O
effects	O
on	O
baclofen	O
,	O
muscimol	B-NEG
,	O
aminooxyacetic	B-NEG
acid	I-NEG
(	O
AOAA	O
)	O
and	O
thiosemicarbazide	O
induced	O
changes	O
in	O
locomotor	O
activity	O
,	O
Suanzaorentang	O
significantly	O
decreased	O
vanillylmandelic	B-NEG
acid	I-NEG
(	O
VMA	B-NEG
)	O
in	O
striatum	O
and	O
hippocampus	O
,	O
homovanillic	B-NEG
acid	I-NEG
(	O
HVA	B-NEG
)	O
in	O
hippocampus	O
and	O
5-hydroxyindol	B-NEG
acetic	I-NEG
acid	I-NEG
(	O
5-HIAA	B-NEG
)	O
in	O
striatum	O
and	O
hypothalamus	O
,	O
Suanzaorentang	O
significantly	O
reversed	O
the	O
alpha-methyltyrosine	O
(	O
alpha-MT	O
)	O
produced	O
decrease	O
in	O
DA	B-NEG
concentrations	O
in	O
striatum	O
and	O
hippocampus	O
,	O
and	O
(	O
6	O
)	O
Suanzaorentang	O
significantly	O
reversed	O
the	O
p-CPA	O
produced	O
decrease	O
in	O
5-HT	B-NEG
concentrations	O
on	O
amygdala	O
.	O

-DOCSTART-	O

These	O
result	O
indicate	O
that	O
Shosaikoto	O
facilitates	O
oxidized	O
LDL	O
catabolism	B-NEG
in	O
macrophages	O
,	O
resulting	O
in	O
the	O
augmentation	O
of	O
oxidized	B-NEG
LDL	I-NEG
uptake	I-NEG
and	O
the	O
elimination	O
of	O
cholesterol	B-NEG
from	O
macrophages	O
by	O
HDL	O
.	O

-DOCSTART-	O

The	O
results	O
showed	O
that	O
pretreatment	O
of	O
rats	O
with	O
Guilingji	O
decreased	O
the	O
levels	O
of	O
TBARS	B-NEG
in	O
the	O
left	O
cortex	O
,	O
midbrain	O
,	O
and	O
olfactory	O
lobe	O
,	O
and	O
increased	O
the	O
SOD	B-NEG
activity	I-NEG
in	O
the	O
midbrain	O
and	O
hypothalamus	O
.	O

-DOCSTART-	O

AIM	O
To	O
observe	O
the	O
therapeutic	O
effects	O
of	O
Sishengtang	O
decoction	O
in	O
alleviating	O
the	O
toxic	B-NEG
and	O
side	O
effects	O
of	O
transarterial	O
embolization	O
(	O
TAE	O
)	O
.	O

-DOCSTART-	O

Studies	O
in	O
non-T	O
cells	O
have	O
demonstrated	O
regulation	O
of	O
the	O
tyrosine	O
focal	O
adhesion	O
kinase	O
pp125FAK	B-NEG
by	O
beta	O
1	O
integrin	O
engagement	O
and	O
,	O
most	O
recently	O
,	O
indicate	O
a	O
role	O
for	O
pp125FAK	O
in	O
linking	O
integrin-mediated	O
signal	O
transduction	O
to	O
the	O
Ras	O
pathway	O
(	O
Schaller	O
,	O
M	O
.	O
D	O
.	O
,	O
and	O
J	O
.	O
T	O
.	O
Parsons	O
,	O
1994	O
,	O
Curr	O
.	O
Opin	O
.	O
Cell	O
.	O
Biol	O
.	O
6	O
705-710	O
Schlaepfer	O
,	O
D	O
.	O
D	O
.	O
,	O
S	O
.	O
K	O
.	O
Hanks	O
,	O
T	O
.	O
Hunter	O
,	O
and	O
P	O
.	O
Van	O
der	O
Geer	O
.	O
1994	O
.	O
Nature	O
(	O
Lond	O
.	O
)	O
,	O
372	O
786-790	O
)	O
.	O

-DOCSTART-	O

Also	O
,	O
Sijunzitang	O
could	O
increase	O
the	O
level	B-NEG
of	I-NEG
IL-2	I-NEG
in	O
blood	O
and	O
the	O
phagocytic	B-NEG
function	I-NEG
of	I-NEG
neutrophil	I-NEG
(	O
P	O
0	O
.	O
05	O
)	O
the	O
Taohong	O
Siwutang	O
could	O
lower	O
the	O
level	O
of	O
CIC	B-NEG
to	O
patients	O
with	O
blood	B-NEG
stasis	I-NEG
syndrome	I-NEG
(	O
P	O
0	O
.	O
01	O
)	O
,	O
increase	O
the	O
activity	B-NEG
of	I-NEG
NK	I-NEG
cells	I-NEG
(	O
P	O
0	O
.	O
05	O
)	O
.	O

-DOCSTART-	O

The	O
effect	O
of	O
herbal	O
components	O
of	O
Tokishakuyakusan	O
on	O
progestin	B-NEG
levels	O
in	O
serum	O
and	O
ovarian	O
tissue	O
from	O
rats	O
treated	O
with	O
PMS	O
and	O
hCG	O
was	O
examined	O
in	O
vivo	O
.	O

-DOCSTART-	O

Twenty-seven	O
infertile	B-NEG
women	O
with	O
hyperprolactinemia	B-NEG
were	O
treated	O
with	O
Hachimijiogan	O
(	O
5	O
.	O
0	O
to	O
10	O
.	O
0	O
g	O
day	O
)	O
,	O
Chinese	O
herbal	O
medicine	O
.	O

-DOCSTART-	O

The	O
degree	O
of	O
penetration	O
into	O
the	O
stomach	B-NEG
and	O
duodenum	B-NEG
of	O
the	O
horse	O
by	O
bot	O
fly	O
larvae	O
,	O
Gasterophilus	O
intestinalis	O
(	O
De	O
Geer	O
)	O
and	O
G	O
.	O
nasalis	O
(	O
Linnaeus	O
)	O
(	O
Diptera	O
Gasterophilidae	O
)	O
was	O
evaluated	O
.	O

-DOCSTART-	O

After	O
treatment	O
with	O
baoyuantang	O
,	O
the	O
amount	B-NEG
of	I-NEG
Hb	I-NEG
was	O
increased	O
and	O
creatinine	B-NEG
decreased	O
in	O
CRF	B-NEG
patients	O
,	O
and	O
its	O
effective	O
rate	O
reached	O
83	O
.	O

3	O
.	O

-DOCSTART-	O

Shengmaiyin	O
that	O
maintains	O
interior	O
substances	O
in	O
the	O
plate	O
layer	O
bodies	O
proves	O
more	O
effective	O
than	O
Danshen-Chuanxiong	O
mixture	O
,	O
while	O
the	O
latter	O
excels	O
in	O
preventing	O
capillary	B-NEG
contraction	I-NEG
,	O
thus	O
improving	O
blood	B-NEG
circulation	I-NEG
.	O

-DOCSTART-	O

Effects	O
of	O
Kamikihito	O
,	O
a	O
traditional	O
Chinese	O
medicine	O
,	O
on	O
neurotransmitter	B-NEG
receptor	I-NEG
binding	I-NEG
in	O
the	O
aged	O
rat	O
brain	O
determined	O
by	O
in	O
vitro	O
autoradiography	O
(	O
2	O
)	O
changes	O
in	O
GABAA	B-NEG
and	I-NEG
benzodiazepine	I-NEG
receptor	I-NEG
binding	I-NEG
.	O

-DOCSTART-	O

In	O
addition	O
,	O
the	O
modulatory	O
effects	O
of	O
Samultang	O
on	O
LPS	B-NEG
PMA	B-NEG
-induced	O
cytotoxicity	B-NEG
and	O
NO	B-NEG
production	I-NEG
could	O
be	O
mimicked	O
by	O
exogenous	O
treatments	O
of	O
N	O
(	O
G	O
)	O
MMA	O
,	O
a	O
nitric	O
oxide	O
synthase	O
(	O
NOS	O
)	O
inhibitor	O
,	O
and	O
pyrrolidine	O
dithiocarbamate	O
(	O
PDTC	O
)	O
,	O
a	O
strong	O
NF-kappaB	O
inhibitor	O
.	O

-DOCSTART-	O

Furthermore	O
,	O
although	O
oxidized	O
low	O
density	O
lipoprotein	O
(	O
LDL	O
)	O
and	O
lysophosphatidylcholine	O
(	O
LPC	O
)	O
reduced	O
NO	O
production	O
,	O
macrophages	O
prepared	O
from	O
mice	O
treated	O
with	O
Shosaikoto	O
at	O
a	O
dose	O
of	O
1	O
.	O

2	O
g	O
kg	O
d	O
restored	O
the	O
reduced	O
NO	B-NEG
production	I-NEG
by	O
them	O
as	O
well	O
as	O
by	O
hypercholesterolemia	B-NEG
.	O

-DOCSTART-	O

Successful	O
treatment	O
of	O
a	O
hyperprolactinemic	O
infertile	B-NEG
woman	O
with	O
a	O
pituitary	B-NEG
microadenoma	I-NEG
using	O
hachimijiogan	O
.	O

-DOCSTART-	O

Injection	O
of	O
10	O
IU	O
pregnant	O
mare	O
serum	O
gonadotropin	O
(	O
PMS	O
)	O
on	O
day	O
27	O
of	O
age	O
gradually	O
increased	O
DNA	O
polymerase	O
alpha	O
activity	O
in	O
uteri	O
,	O
while	O
concomitant	O
treatment	O
with	O
PMS	O
and	O
200	O
micrograms	O
Tokishakuyakusan	O
(	O
TS	O
)	O
,	O
Keishibukuryogan	O
(	O
KB	O
)	O
or	O
Unkeito	O
(	O
UT	O
)	O
suppressed	O
the	O
enzyme	B-NEG
activity	I-NEG
,	O
with	O
a	O
most	O
remarkable	O
effect	O
of	O
KB	O
.	O

-DOCSTART-	O

OBJECTIVE	O
To	O
observe	O
the	O
changes	O
of	O
oxidation	O
and	O
hepatic	O
cells	O
apoptosis	O
in	O
the	O
wet-heat	B-NEG
syndrome	I-NEG
rat	O
model	O
,	O
and	O
the	O
effect	O
of	O
qingxiangsan	O
on	O
inhibiting	O
oxidation	O
and	O
hepatic	O
cells	O
apoptosis	O
.	O

-DOCSTART-	O

Moreover	O
,	O
Shosaikoto	O
did	O
not	O
affect	O
the	O
induction	O
of	O
TAT	B-NEG
activity	I-NEG
by	O
butyryl-adenosine	O
3	O
,	O
5	O
-cyclic	O
monophosphate	O
.	O

-DOCSTART-	O

As	O
a	O
result	O
,	O
the	O
maximum	O
cell	O
density	O
obtained	O
after	O
the	O
addition	O
of	O
Ninjinyoeito	O
was	O
found	O
to	O
be	O
400	O
ng	O
ml	O
,	O
and	O
its	O
inhibitory	O
effect	O
on	O
the	O
development	O
of	O
endothelial	B-NEG
injury	I-NEG
was	O
also	O
observed	O
.	O

-DOCSTART-	O

Moreover	O
,	O
300	O
mg	O
kg	O
or	O
1	O
g	O
kg	O
of	O
Maimendongtang	O
markedly	O
attenuated	O
human	B-NEG
neutrophil	I-NEG
elastase	I-NEG
(	O
HNE	O
)	O
or	O
DNA-induced	O
decrease	O
in	O
MCTV	B-NEG
although	O
100	O
mg	O
kg	O
of	O
Maimendongtang	O
had	O
little	O
effect	O
.	O

-DOCSTART-	O

Effects	O
of	O
Guilingji	O
on	O
brain	B-NEG
monoamines	O
and	O
their	O
metabolites	O
in	O
mice	O
.	O

-DOCSTART-	O

Moreover	O
,	O
frequency	O
and	O
severity	O
of	O
hematuria	B-NEG
were	O
significantly	O
decreased	O
in	O
cats	O
fed	O
the	O
choreito-containing	O
diet	O
.	O

-DOCSTART-	O

Studies	O
on	O
the	O
suanzaorentang	O
in	O
the	O
treatment	O
of	O
anxiety	B-NEG
.	O

-DOCSTART-	O

Effects	O
of	O
Zuoguiwan	O
(	O
ZGW	O
,	O
a	O
prescription	O
for	O
reinforcing	O
Kidney	O
Yin	O
)	O
on	O
early	B-NEG
embryonic	I-NEG
development	I-NEG
were	O
observed	O
by	O
using	O
embryonic	O
developmental	O
retardation	O
model	O
of	O
mice	O
formed	O
by	O
alcohol	O
.	O

-DOCSTART-	O

On	O
the	O
other	O
hand	O
,	O
the	O
administration	O
of	O
Shosaikoto	O
,	O
1	O
.	O

2	O
g	O
kg	O
p	O
.	O
o	O
.	O
,	O
for	O
7	O
d	O
reduced	O
the	O
number	O
of	O
hemolytic	B-NEG
plaque	I-NEG
forming	I-NEG
cells	I-NEG
(	O
HPFC	O
)	O
in	O
spleen	O
cells	O
.	O

-DOCSTART-	O

METHODS	O
Using	O
cytobiologic	O
and	O
molecular	O
biologic	O
technique	O
to	O
observe	O
the	O
effects	O
of	O
Reduqing	O
on	O
HL-60	B-NEG
cells	I-NEG
in	O
producing	O
inflammatory	O
cytokine	O
secreting	O
TNF	O
alpha	O
(	O
sTNF	O
alpha	O
)	O
and	O
on	O
mRNA	O
expression	O
of	O
TNF	B-NEG
alpha	I-NEG
converting	I-NEG
enzyme	I-NEG
(	O
TACE	B-NEG
)	O
.	O

-DOCSTART-	O

Thirty	O
infertile	B-NEG
male	I-NEG
patients	O
were	O
orally	O
given	O
Goshajinkigan	O
at	O
a	O
daily	O
dose	O
of	O
5	O
.	O

0	O
g	O
for	O
three	O
months	O
or	O
more	O
.	O

-DOCSTART-	O

Effect	O
of	O
hachimijiogan	O
,	O
an	O
oriental	O
herbal	O
medicinal	O
mixture	O
,	O
on	O
experimental	O
amnesia	B-NEG
in	O
mice	O
.	O

-DOCSTART-	O

The	O
decrease	O
of	O
7S	O
HA	B-NEG
titer	O
of	O
the	O
serum	O
by	O
the	O
treatment	O
with	O
prednisolone	O
,	O
0	O
.	O

01	O
g	O
kg	O
s	O
.	O

c	O
.	O
,	O
was	O
also	O
inhibited	O
by	O
the	O
combination	O
with	O
Shosaikoto	O
,	O
1	O
.	O

2	O
g	O
kg	O
p	O
.	O
o	O
.	O

-DOCSTART-	O

A	O
controlled	O
comparative	O
double-blind	O
clinical	O
trial	O
was	O
set	O
up	O
to	O
assess	O
the	O
anxiolytic	B-NEG
effect	I-NEG
of	O
suanzaorentang	O
.	O

-DOCSTART-	O

The	O
dose-response	O
for	O
the	O
induction	O
of	O
acentric	B-NEG
chromosome	I-NEG
fragments	O
was	O
determined	O
in	O
neuroblasts	O
of	O
the	O
grasshopper	O
embryo	O
(	O
Chortophaga	O
viridifasciata	O
De	O
Geer	O
,	O
Orthoptera	O
Acrididae	O
)	O
exposed	O
in	O
vitro	O
to	O
four	O
direct-acting	O
chemical	O
known	O
to	O
be	O
mutagenic	O
,	O
clastogenic	O
,	O
and	O
carcinogenic	O
4-nitroquinoline-1-oxide	O
(	O
4NQO	O
)	O
,	O
N-methyl-N-nitro-N-nitrosoguanidine	O
(	O
MNNG	O
)	O
,	O
Adriamycin	O
(	O
ADM	O
)	O
,	O
and	O
bleomycin	O
(	O
BLM	O
)	O
.	O

-DOCSTART-	O

Oral	O
administration	O
of	O
shosaikoto	O
influences	O
the	O
synthesis	O
of	O
humoral	O
factors	O
such	O
as	O
the	O
interleukins	B-NEG
,	O
nitric	B-NEG
oxide	I-NEG
and	O
prostaglandins	B-NEG
in	O
macrophages	O
.	O

-DOCSTART-	O

NG-monomethyi-L-argine	O
(	O
NGMMA	O
)	O
,	O
a	O
specific	O
inhibitor	O
of	O
nitric	O
oxide	O
synthase	O
(	O
NOS	O
)	O
,	O
significantly	O
blocks	O
the	O
protective	O
effects	O
of	O
Jagamchotang	O
on	O
the	O
cells	B-NEG
after	O
ischemia	B-NEG
reperfusion	I-NEG
.	O

-DOCSTART-	O

This	O
study	O
was	O
to	O
compare	O
the	O
effects	O
of	O
Pingandan	O
with	O
those	O
of	O
scopolamine	O
and	O
dramamine	O
on	O
motion	B-NEG
sickness	I-NEG
(	O
MS	O
)	O
and	O
nystagmus	B-NEG
.	O

-DOCSTART-	O

METHODS	O
BALB	O
c	O
mouse	O
models	O
of	O
colonic	B-NEG
adenocarcinoma	I-NEG
with	O
liver	O
metastases	O
were	O
established	O
by	O
intrasplenic	O
injection	O
of	O
colonic	O
adenocarcinoma	O
cells	O
(	O
CT26	O
)	O
to	O
receive	O
treatment	O
with	O
the	O
three	O
representative	O
classical	O
circulation-promoting	B-NEG
and	O
blood	B-NEG
stasis-removing	I-NEG
prescriptions	O
of	O
traditional	O
Chinese	O
medicine	O
,	O
namely	O
Guizhifuling	O
pills	O
,	O
Didang	O
Tang	O
and	O
Danshenyin	O
,	O
respectively	O
.	O

-DOCSTART-	O

The	O
H-DNA	O
repeat	O
unit	O
of	O
Herpesvirus	B-NEG
saimiri	O
strain	O
11	O
was	O
cloned	O
in	O
plasmid	O
vector	O
pAGO	O
,	O
and	O
the	O
nucleotide	O
sequence	O
was	O
determined	O
by	O
the	O
dideoxy	O
chain	O
termination	O
method	O
.	O

-DOCSTART-	O

Asthmatic	B-NEG
children	O
and	O
Chinese	O
medicine	O
.	O

Scientific	O
study	O
of	O
shoseiryuto	O
and	O
saibokuto	O
.	O

-DOCSTART-	O

Effect	O
of	O
rat	O
serum	O
containing	O
Biejiajian	O
oral	O
liquid	O
on	O
proliferation	O
of	O
rat	O
hepatic	B-NEG
stellate	I-NEG
cells	I-NEG
.	O

-DOCSTART-	O

Hormonal	B-NEG
imbalance	I-NEG
in	O
both	O
sexes	O
may	O
be	O
treated	O
with	O
Chinese	O
herbal	O
mixtures	O
such	O
as	O
Hachimijiogan	O
,	O
herbs	O
such	O
as	O
Vitex	O
agnus-castus	O
,	O
or	O
a	O
blend	O
of	O
essential	O
oils	O
designed	O
to	O
treat	O
amenorrhoea	B-NEG
or	O
scanty	B-NEG
irregular	I-NEG
periods	I-NEG
.	O

-DOCSTART-	O

These	O
results	O
suggest	O
that	O
Hachimijiogan	O
increases	O
serum	O
estradiol-17	B-NEG
beta	I-NEG
levels	I-NEG
and	O
improves	O
spermatogenesis	B-NEG
in	O
oligozoospermic	O
men	O
.	O

-DOCSTART-	O

Administration	O
of	O
Saireito	O
,	O
a	O
Saiko	O
agent	O
(	O
a	O
Chinese	O
herbal	O
drug	O
)	O
,	O
via	O
a	O
stomach	O
cannula	O
stimulates	O
ACTH	B-NEG
release	O
and	O
proopiomelanocortin	B-NEG
,	O
the	O
precursor	B-NEG
for	I-NEG
ACTH	I-NEG
,	O
gene	B-NEG
expression	I-NEG
in	O
the	O
rat	O
anterior	O
pituitary	O
.	O

-DOCSTART-	O

Resistance	O
of	O
head	B-NEG
louse	I-NEG
(	O
Pediculus	O
humanus	O
capitis	O
de	O
Geer	O
)	O
to	O
DDT	O
in	O
Malaysia	O
.	O

-DOCSTART-	O

The	O
effect	O
of	O
Chinese	O
drug	O
therapy	O
on	O
the	O
patients	O
with	O
male	B-NEG
infertility	I-NEG
.	O

1	O
.	O

Concomitant	O
administration	O
of	O
ninjinto	O
and	O
hachimijiogan	O
on	O
patients	O
with	O
male	O
infertility	O
.	O

-DOCSTART-	O

The	O
concept	O
Sexual	B-NEG
Content-Induced	I-NEG
Delay	I-NEG
(	O
SCID	B-NEG
)	O
refers	O
to	O
a	O
hesitancy	B-NEG
in	O
decision	O
making	O
related	O
to	O
erotic	O
material	O
(	O
Geer	O
Bellard	O
,	O
1996	O
Geer	O
Melton	O
,	O
1997	O
)	O
.	O

-DOCSTART-	O

The	O
effects	O
of	O
three	O
Chinese	O
ancient	O
prescriptions	O
,	O
Bazhengsan	O
,	O
Pixiefenqingyin	O
and	O
Wulinsan	O
were	O
determined	O
in	O
vitro	O
against	O
4	O
strains	O
of	O
Diplocous	O
gonorrhoeaes	B-NEG
.	O

-DOCSTART-	O

Protection	O
mechanism	O
of	O
huanshaodan	O
decoction	O
in	O
the	O
brain	B-NEG
.	O

-DOCSTART-	O

To	O
investigate	O
the	O
protective	O
effects	O
of	O
Wuyaoshunqisan	O
against	O
H2O2-induced	O
apoptosis	B-NEG
in	O
the	O
central	O
nervous	O
system	O
,	O
the	O
3-	O
(	O
4	O
,	O
5-dimethylthiazol-2-yl	O
)	O
-2	O
,	O
5-diphenyltetrazolium	O
bromide	O
(	O
MTT	O
)	O
assay	O
,	O
the	O
terminal	O
deoxynucleotidyl	O
transferase	O
(	O
TdT	O
)	O
-mediated	O
dUTP	O
nick	O
end-labeling	O
(	O
TUNEL	O
)	O
method	O
,	O
flow	O
cytometric	O
analysis	O
,	O
and	O
the	O
DNA	O
fragmentation	O
assay	O
were	O
performed	O
on	O
cells	O
of	O
the	O
hippocampal	O
cell	O
line	O
HiB5	O
.	O

-DOCSTART-	O

According	O
to	O
the	O
plasmid	O
,	O
the	O
effect	O
of	O
the	O
HSVtk	O
GCV	O
system	O
was	O
confirmed	O
by	O
in	O
vivo	O
experiments	O
and	O
was	O
objectified	O
by	O
a	O
higher	O
tumor	B-NEG
weight	O
reduction	O
with	O
pCMVtk	O
(	O
49	O
)	O
than	O
pAGo	O
(	O
27	O
)	O
.	O

-DOCSTART-	O

OBJECTIVE	O
To	O
determine	O
the	O
effects	O
of	O
the	O
takushya	O
portion	O
of	O
choreito	O
,	O
a	O
traditional	O
Chinese	O
treatment	O
for	O
urolithiasis	B-NEG
,	O
on	O
urine	B-NEG
and	O
struvite	B-NEG
crystal	I-NEG
variables	O
in	O
cats	O
fed	O
diets	O
containing	O
takushya	O
.	O

-DOCSTART-	O

Sannoshashinto	O
,	O
Shosaikoto	O
and	O
Daisaikoto	O
reduced	O
the	O
hypercholesterolemia	B-NEG
induced	O
by	O
a	O
high	O
cholesterol	O
diet	O
and	O
Sannoshashinto	O
and	O
Daisaikoto	O
improved	O
the	O
atherogenetic	O
index	O
.	O

-DOCSTART-	O

Hypercholesterolemia	O
in	O
rabbits	O
gradually	O
reduced	O
the	O
monocyte	O
number	O
in	O
peripheral	O
blood	O
,	O
whereas	O
Shosaikoto	O
treatment	O
suppressed	O
this	O
decrease	O
in	O
circulating	O
monocytes	B-NEG
.	O

-DOCSTART-	O

Conservative	O
treatment	O
of	O
benign	B-NEG
prostatic	I-NEG
hypertrophy	I-NEG
--clinical	O
effects	O
of	O
increased	O
administration	O
of	O
Hachimijiogan	O
and	O
the	O
relation	O
between	O
these	O
effects	O
and	O
the	O
Sho	O
of	O
Chinese	O
medicine	O
.	O

-DOCSTART-	O

Hochuekkito	O
was	O
administered	O
in	O
2	O
.	O

5	O
g	O
doses	O
three	O
times	O
a	O
day	O
to	O
162	O
patients	O
who	O
complained	O
of	O
anorexia	B-NEG
or	O
lassitude	B-NEG
because	O
of	O
genitourinary	B-NEG
cancer	I-NEG
.	O

-DOCSTART-	O

Plasmid	O
pMH1A	O
was	O
derived	O
from	O
pAGO	O
by	O
deletion	O
of	O
2067	O
bp	O
of	O
DNA	O
sequence	O
from	O
pBR322	O
and	O
105	O
bp	O
from	O
the	O
HSV-1	B-NEG
TK	I-NEG
gene	I-NEG
.	O

-DOCSTART-	O

In	O
all	O
groups	O
fed	O
individual	O
components	O
of	O
Wulingsan	O
,	O
the	O
severity	O
of	O
calcinosis	B-NEG
was	O
almost	O
the	O
same	O
as	O
that	O
in	O
the	O
group	O
fed	O
the	O
high	O
phosphorus	O
diet	O
(	O
1	O
.	O
5	O
P	O
)	O
.	O

-DOCSTART-	O

Effects	O
of	O
Tokishakuyakusan	O
,	O
Keishibukuryogan	O
and	O
Unkeito	O
on	O
DNA	B-NEG
polymerase	I-NEG
alpha	I-NEG
activity	I-NEG
in	O
PMS-treated	O
immature	O
rat	O
uterus	O
incubated	O
in	O
vitro	O
.	O

-DOCSTART-	O

This	O
case	O
suggests	O
that	O
methylprednisolone	O
treatment	O
may	O
be	O
insufficient	O
for	O
Shosaikoto-induced	O
pulmonary	B-NEG
edema	I-NEG
,	O
and	O
that	O
mechanical	O
ventilation	O
with	O
PEEP	O
is	O
very	O
effective	O
.	O

-DOCSTART-	O

Ganciclovir-resistant	O
mutant	O
759rD100	O
derived	O
from	O
human	O
cytomegalovirus	B-NEG
strain	O
AD169	O
contains	O
two	O
resistance	O
mutations	O
,	O
one	O
of	O
which	O
is	O
in	O
the	O
UL97	O
gene	O
and	O
results	O
in	O
decreased	O
ganciclovir	O
phosphorylation	O
in	O
infected	O
cells	O
V	O
.	O

Sullivan	O
,	O
C	O
.	O

L	O
.	O

Talarico	O
,	O
S	O
.	O

C	O
.	O

Stanat	O
,	O
M	O
.	O

Davis	O
,	O
D	O
.	O

M	O
.	O

Coen	O
,	O
and	O
K	O
.	O

K	O
.	O

Biron	O
,	O
Nature	O
(	O
London	O
)	O
358	O
162-164	O
,	O
1992	O
.	O

-DOCSTART-	O

Therapeutic	O
strategies	O
comply	O
with	O
SIGO	O
1999	O
guidelines	O
for	O
therapy	O
of	O
CIN	O
and	O
with	O
European	O
guidelines	O
for	O
cervical	O
condylomata	B-NEG
partially	O
.	O

-DOCSTART-	O

METHODS	O
Modified	O
Sanjiasan	O
Granule	O
(	O
MSG	O
)	O
,	O
a	O
representative	O
recipe	O
of	O
NKIR	O
,	O
was	O
used	O
to	O
treat	O
26	O
patients	O
with	O
vascular	B-NEG
dementia	I-NEG
,	O
7	O
g	O
per	O
day	O
orally	O
for	O
one	O
month	O
as	O
one	O
therapeutic	O
course	O
,	O
and	O
the	O
effect	O
of	O
treatment	O
was	O
evaluated	O
by	O
psychic	O
evaluation	O
table	O
.	O

-DOCSTART-	O

Effect	O
of	O
shengmaisan	O
on	O
serum	O
lipid	B-NEG
peroxidation	I-NEG
in	O
acute	O
viral	B-NEG
myocarditis	I-NEG
.	O

-DOCSTART-	O

The	O
nuclear	O
staining	O
of	O
PC12	O
cells	O
clearly	O
showed	O
that	O
Hwansodan	O
attenuated	O
nuclear	O
condensation	B-NEG
and	O
fragmentation	B-NEG
,	O
which	O
represents	O
typical	O
neuronal	O
apoptotic	B-NEG
characteristics	O
.	O

